510(k) K182692
K182692 is an FDA 510(k) premarket notification submitted by Becton, Dickinson and Company for the device "BD MAX CTGCTV2, BD MAX System". The FDA issued a decision of Substantially Equivalent on January 8, 2019. The device falls under product code OUY (Trichomonas Vaginalis Nucleic Acid Amplification Test System), a Class II device regulated under 21 CFR 866.3860. Becton, Dickinson and Company has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 8, 2019
- Date Received
- September 27, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Trichomonas Vaginalis Nucleic Acid Amplification Test System
- Device Class
- Class II
- Regulation Number
- 866.3860
- Review Panel
- MI
- Submission Type
In vitro nucleic acid amplification test for the qualitative detection of ribosomal rna from trichomonas vaginalis as an aid in the diagnosis of trichomoniasis from vaginal, cervical, urogenital and gynecological specimens from symptomatic patients